The setup
If you handed a generalist sector analyst the financials of the top eight U.S. MSOs and the top five Canadian LPs — with the names redacted — they'd value the MSOs at a premium. They generate more revenue, higher margins, real free cash flow, and growth that doesn't depend on M&A.
The market does the opposite. Why?
The numbers
| Metric | Top 8 U.S. MSOs | Top 5 Canadian LPs |
|---|---|---|
| Aggregate revenue (TTM) | $7.2B | $1.9B |
| Aggregate gross margin | 48% | 31% |
| Aggregate adj. EBITDA | $1.6B | -$80M |
| Free cash flow | $1.1B | -$240M |
| EV/EBITDA | 6.2x | n/m |
| EV/Revenue | 1.8x | 14.8x |
The MSOs are profitable, scaled, and cash-generative. The LPs are not. Yet on EV/revenue, the LPs trade at 8x the MSO multiple.
What explains the gap
1. Listing venue — Canadian LPs trade on NASDAQ/NYSE; MSOs trade on Canadian exchanges and the U.S. OTC. Institutional ownership for the LPs averages 18%; for MSOs it's under 4%.
2. Index inclusion — Canadian LPs are eligible for sector ETFs, broad-market funds, and Russell indices. MSOs are eligible for none.
3. Tax structure — 280E hits MSOs at the federal level. Canadian LPs pay normal corporate tax.
4. Banking — MSOs cannot access basic banking services from major U.S. banks. Cash management costs run 200–400 bps higher.
None of these are operating disadvantages. They are structural — and structural gaps close when the structure changes.
What closes the gap
Rescheduling alone closes roughly half the gap — eliminating 280E and signaling federal de-risking. Full closure requires uplisting eligibility, which requires either SAFER Banking passage or a more aggressive DEA interpretation than is currently proposed.
What it means for portfolio construction
If you believe rescheduling is more likely than not, the asymmetric trade is owning the MSOs — not the LPs. The LPs already trade as if every catalyst has been delivered. The MSOs trade as if none of them will be.
Bottom line
The 8x revenue-multiple gap between LPs and MSOs is the single largest structural mispricing in the cannabis sector. It is not a fundamentals call. It is a regime-change call.